• News
  • SAN DIEGO
  • Finance

Dexcom gains FDA approval; stocks rise

Share prices in San Diego's Dexcom Inc. rose nearly 6 percent in after-hours trading Tuesday after the company announced it had received FDA approval for a new system aimed at providing diabetic patients and their doctors with real-time information about their sugar levels.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Dexcom Inc.

Company Website

5555 Oberlin Drive
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
DXCM
56.55
  -0.30  
- 0.53%
703,218,000
58.32
28.09

Insider Trade Data

Date Insider Shares Type Value
12/15/2014 Lister, John 5,750 Exchange $26,335
12/15/2014 Gregg, Terrance H 35,000 Sell $1,862,977
12/15/2014 Gregg, Terrance H 25,000 Exchange $171,250
12/12/2014 Sayer, Kevin R 10,000 Sell $539,700
12/12/2014 Lister, John 3,079 Sell $164,869

Dexcom Inc. Executive(s):

Terrance Gregg

  • Chief Executive Officer, Director

Kevin Sayer

  • Director, President

Patrick Murphy

  • Assist. General Counsel

Similar Companies

NAICS - -
Subscribe Today!